| ABAC | Accelerated Brain-Ageing Chemokine |
| AD | Alzheimer’s Disease |
| Anti-CCL11 | Eotaxin-1 Antibody |
| ASD | Autism Spectrum Disorder |
| ASM | Airway Smooth Muscle |
| BBB | Blood-Brain Barrier |
| BMP | Bone Morphogenetic Proteins |
| CANTAB | Cambridge Neuropsychological Test Automated Battery |
| CCL | C-C motif chemokine Ligand |
| CCL-11 | Eotaxin-1, eosinophil chemotactic protein |
| CCL-2 | C-C motif chemokine Ligand 2 |
| CCL-5 | C-C motif chemokine Ligand 5 |
| CCL-24 | Eotaxin-2 |
| CCL-26 | Eotaxin-3 |
| CCR | Chemokine Receptors |
| Cdk5 | Cyclin-dependent kinase 5 |
| CERAD | Consortium to Establish a Registry for Alzheimer’s Disease |
| CIRS | Compensatory Immune-Regulatory System |
| CNS | Central Nervous System |
| CSF | Cerebrospinal Fluid |
| CX3CL1 | C-X3-C motif chemokine Ligand 1 |
| CXCL | C-X-C motif Ligand |
| CXCR3 | C-X-C chemokine receptor 3 |
| CXCL9 | C-C motif chemokine Ligand 9 |
| CXCL8 | C-C motif chemokine Ligand 8 |
| CXCL12 | C-C motif chemokine Ligand 12 |
| DKK1 | Dickkoph-1-related protein |
| DRSP | Daily Record of Severity of Problems |
| EAE | Autoimmune Encephalomyelitis |
| ECDC | Endogenous Cognition Deteriorating Chemokine |
| FGF-2 | Fibroblast Growth Factor- 2 |
| GDF | Growth Differentiation Factor |
| GSK3 | Glycogen Synthase Kinase-3β |
| HPAEC | Human Pulmonary Artery Endothelial Cells |
| IFN-γ | Interferon-gamma |
| IgA | Immunoglobulin A |
| IgG4 | Immunoglobulin G4 |
| IL-4 | Interleukin-4 |
| IL-6 | Interleukin-6 |
| IL-10 | Interleukin-10 |
| IL-13 | Interleukin-13 |
| IL-1β | Interleukin-1 beta |
| IL-1RA | Interleukin-1 Receptor Antagonist |
| MCAS | Menstrual Cycle-Associated Syndrome |
| MCP | Monocyte Chemoattractant Protein |
| MMSE | Mini-Mental State Examination |
| MS | Multiple Sclerosis |
| NF-κB | Nuclear Factor-kappa B |
| NMO | Neuromyelitis Optica |
| NMOSD | NMO Spectrum Disorders |
| NOX1 | NADPH Oxidase 1 |
| OCD | Obsessive-Compulsive Disorder |
| OTS | One-Touch Stockings of Cambridge |
| PMS | Premenstrual Syndrome |
| ROS | Reactive Oxygen Species |
| SCZ | Schizophrenia |
| SNPs | Single-Nucleotide Polymorphisms |
| sTNF-R1 | Soluble Tumour Necrosis Factor-Receptor 1 |
| sTNF-R2 | Soluble Tumour Necrosis Factor-Receptor 2 |
| TGF-β1 | Transforming Growth Factor-beta 1 |
| Th-1 | T helper-1 |
| Th-2 | T helper-2 |
| Th-17 | T helper-17 |
| TNF-α | Tumour Necrosis Factor-alpha |
| TOAST | Trial of ORG 10172 in Acute Stroke Treatment |
| Treg | T regulatory |
| TRYCAT | Tryptophan Catabolites |
| VFT | Verbal Fluency Test |